Epigenetic regulation of non-coding DNA in placental development and disorders

The human placenta is an epigenetically exceptional organ that must execute rapid proliferation, lineage bifurcation, and controlled invasion while maintaining immune tolerance at the maternal-fetal interface. Trophoblast lineages operate within a developmentally programmed "pseudo-malignant" regulatory state, characterized by global DNA hypomethylation, large partially methylated domains, and dynamic chromatin transitions across gestation. This configuration enables transcriptional plasticity but also creates vulnerability to maternal and environmental exposures, which can leave persistent epigenetic effects associated with fetal growth restriction, preeclampsia, preterm birth, and pregnancy loss. Placental health and disease therefore cannot be understood through protein-coding genes alone. The non-coding genome, comprising promoters, enhancers, enhancer-promoter networks, and non-coding RNAs is extensively rewired in trophoblast, with retrotransposons providing a major source of regulatory innovation. Epigenetic mechanisms coordinate these elements to establish trophoblast-specific transcriptional programs, and perturbation at any layer can disrupt differentiation, invasion, endocrine signaling, and immune modulation. Maternal inflammation, hypoxia, toxins, metabolic and psychological stress reshape epigenetically labile non-coding regions, positioning the placenta as both a developmental sensor and molecular archive of the intrauterine environment. Advances in epigenomic profiling highlight the potential of non-coding epigenetic signatures as early biomarkers, while underscoring ongoing challenges in resolving cell-type-specific regulatory programs and accurately annotating repetitive elements.